baber/WOPTO huggingface dataset:
Patent EP-4076082-A1 (EP)
Title: Éléments pourvus de particules incorporées et leurs procédés de fabrication
Inventor: BRUNO STEPHEN N
IPC: B29D35/14
Filed: 2020-12-11
Abstract: Un élément, par exemple une bande de renfort de chaussure, peut avoir une ou plusieurs régions ayant des particules incorporées et une ou plusieurs régions sans particules incorporées. La ou les régions sans particules incorporées peuvent comprendre une ou plusieurs surfaces externes de l'élément. L'élément peut être formé par chauffage et pressage de sections de matériau dans un moule. L'élément peut être formé par extrusion. Une ou plusieurs des sections de matériau peuvent être dépourvues de particules incorporées.
Patent EP-3992193-A1 (EP)
Inventor: WANG QIAN
IPC: A61K31/519
Filed: 2020-06-28
Abstract: Disclosed are a pyrazolopyrimidine compound, a preparation method for same and applications thereof. Provided in the present invention is the pyrazolopyrimidine compound as represented by formula (II). The compound has improved inhibitory activity with respect to WEE1 kinase.
Patent EP-3916759-A1 (EP)
Inventor: WU PING-HENG
IPC: H01L23/48
Filed: 2020-01-16
Abstract: A wafer and method for manufacturing same, and a semiconductor device. The method for manufacturing a wafer comprises: providing a wafer body, the wafer body being provided with a dicing street (120) for dicing; and forming a dicing silicon through hole (200) at the dicing street (120), the dicing silicon through hole (200) being filled with a protective material to form a dicing line. By providing the dicing silicon through hole (200) filled with the protective material at the dicing street (120) and dicing the dicing silicon through hole (200) when performing wafer dicing, damages caused by dicing stress to an area of a die (110) is prevented, and the width of the dicing street (120) can be effectively narrowed by means of the dicing silicon through hole (200), thereby facilitating the shrinkage of the dicing street (120) and improving the effective utilization rate of a wafer.
Patent EP-3990363-A1 (EP)
Inventor: ADAMS JR RICHARD JOHN
IPC: B65D39/08
Filed: 2020-06-26
Abstract: A lid for an insulated container comprises a flexible gasket configured to facilitate a seal between the lid and an inner wall of the insulated container, and further configured to expand into an interior compartment of the insulated container responsive to a vacuum developing in the interior compartment. A diaphragm chamber is situated opposite the flexible gasket from the interior compartment when the lid is fully engaged with the insulated container. One or more air channels couple the diaphragm chamber to an exterior of the lid. The development of a vacuum in the interior compartment of the insulated container draws a force on the flexible gasket, thereby reducing pressure in the diaphragm chamber. The negative pressure in diaphragm chamber is hack-filled with external air, which enters the lid via the air channels. The hd may then be removed without excessive vacuum forces.
Patent EP-3997702-A1 (EP)
Inventor: MARTINELLI ANDREA
IPC: G11C16/08
Filed: 2020-06-03
Abstract: Methods, systems, and devices for circuit partitioning for a memory device are described. In one example, a memory device may include a set of memory tiles that each include a respective array of memory cells (e.g., in an array level or layer). Each of the memory tiles may include a respective circuit level or layer associated with circuitry configured to operate the respective array of memory cells. The memory device may also include circuitry for communicating data between the memory cells of the set of memory tiles and an input/output component. Aspects of the circuitry for communicating the data may be subdivided into repeatable blocks each configured to communicate one or more bits, and the repeatable blocks and other aspects of the circuitry for communicating the data is distributed across the circuit layer of two or more of the set of memory tiles.
Patent EP-4005978-A1 (EP)
Title: Hydrophobic zeolite, method for producing same and use of same
Inventor: OKANIWA HIROSHI
IPC: B01D15/00
Filed: 2020-07-17
Abstract: To provide a hydrophobic zeolite having both high hydrophobicity and high organic compound adsorption capability, which have not been achieved by conventional zeolites.A hydrophobic zeolite which has a water adsorption of (6 g/100 g zeolite) or less at 25°C at RH 60% and a toluene adsorption of (9 g/100 g zeolite) or more at 25°C under 0.01 kPa.
Patent EP-4030977-A1 (EP)
Inventor: SPURGEON DANIEL A
IPC: G06Q50/28
Filed: 2020-07-31
Abstract: A control system is configured to facilitate transfer of a package between a room in a building and a delivery service outside the room associated with a shipment order. The system controls a shiftable panel of the building to selectively provide a path into and out of the room. The system includes a location sensor and a system processor. The location sensor is configured to sense package location data associated with the location of the package relative to the panel.
Patent EP-3988226-A1 (EP)
Title: Joined body and production method for same
Inventor: MAEDA YASUHIRO
IPC: B21D39/06
Filed: 2020-07-16
Abstract: A joined body 1 includes a tubular first member 10, and a second member 20 including a plate-shaped wall portion 21 in which a through-hole 22 is formed, the first member 10 being inserted into the through-hole 22. The collar member 30 is interposed between the first member 10 and the second member 20 in at least a part of the hole peripheral wall 22a of the through-hole 22. The first member 10 and the second member 20 are joined by expanding the first member 10 at a portion corresponding to the through-hole 22.
Patent EP-4032532-A1 (EP)
Title: Uses of complex of angiotensin ii receptor antagonist metabolite and nep inhibitor in treating heart failure
Inventor: SUN JINGCHAO
IPC: A61K31/41
Filed: 2020-09-18
Abstract: Uses of a complex of an angiotensin II receptor antagonist metabolite and a NEP inhibitor in treating heart failure, specifically related are uses of complex in preparing a medicament for use in heart failure with reduced ejection fraction (HFrEF).
Patent EP-4044564-A1 (EP)
Inventor: CHA SUNGLYONG
IPC: H04M1/02
Filed: 2020-08-03
Abstract: A mobile terminal comprising a first frame, a second frame coupled to the first frame and extendable with respect to the first frame in a first direction, wherein the second frame comprises a third rear portion and a first roller disposed on the third rear portion at a first end of the second frame in the first direction; a flexible display unit comprising a first end and being rolled around the first roller; a driving unit coupled to the first frame and moves the second frame in the first direction or in a second direction opposite to the first direction; and a connection band for curving around a first end of the third rear portion in the second direction, wherein the connection band has a first end connected to the driving unit and a second end coupled to a second end of the flexible display unit.
Patent EP-4016750-A1 (EP)
Inventor: SU ZHANGYUE
IPC: H01R13/6471
Filed: 2020-07-01
Abstract: Embodiments of the present disclosure disclose a connector, an electronic device and an open pluggable OPS device. The connector includes a plurality of first pins and a plurality of second pins. A pair of adjacent first pins is configured to transmit a first signal. A plurality of the second pins are arranged on both sides of a pair of the first pins. The second pin is configured to ground or transmit a second signal. A transmission rate of the first signal is greater than that of the second signal.
Patent EP-4014938-A1 (EP)
Title: Absorbent article
Inventor: ONISHI KAZUAKI
IPC: A61F13/532
Filed: 2020-06-11
Abstract: This absorbent article improves absorption speed and liquid return suppression in a case where a bodily fluid is repeated absorbed. The absorbent article (1) is provided with an absorbent core (9) that includes highly absorbent polymer particles. The absorbent core comprises a first layer (6) on a non-skin-facing side and a second layer (8) on a skin-facing side. The first layer is provided with: a plurality of groove sections (18) that include a plurality of main groove sections (19) that extend in a longitudinal direction and penetrate in a thickness direction; and a plurality of base sections (20) that extend in the longitudinal direction. The main groove sections and the base sections extend in alternation in a transverse direction. The base sections each comprise a base section inner section (36) that is adjacent to the non-skin-facing side of the second layer and a base section outer section (34) that is adjacent to the non-skin-facing side of the base section inner section. The mean density of the highly absorbent polymer particles contained in the base section outer section is lower than the mean density of the highly absorbent polymer particles contained in the base section inner section.
Patent EP-4048174-A1 (EP)
Inventor: GARCIA DIAZ GABRIEL
IPC: A61B17/88
Filed: 2020-10-01
Abstract: A drug delivery system comprising: a plurality of needles; a needle guide for guiding and holding the plurality of needles during insertion into a patient's spine; a syringe containing a drug which is to be delivered into the patient's spine; a port multiplier comprising an inlet port connectable to the syringe and a plurality of outlet ports; and a plurality of tubes for providing fluid connections between the outlet ports of the port multiplier and the plurality of needles.
Patent EP-4020946-A1 (EP)
Title: Antenna fixing structure and electronic device comprising same
Inventor: JEON SEUNGGIL
IPC: H01Q1/02
Filed: 2020-10-08
Abstract: Disclosed is an electronic device. The electronic device may comprise: a bracket which forms a portion of the surface of the electronic device and includes a metal material, a recess being formed in the bracket; and an antenna module including an antenna substrate including a conductive pattern, a first surface including a radiation area from which an RF signal is radiated by the conductive pattern, and a second surface facing the first surface, the conductive pattern being formed on the surface of the antenna substrate or inside the antenna substrate. The antenna module may be disposed inside the recess so that the first surface of the antenna substrate faces an open part of the recess, the recess may be formed by an inner wall including a resting region facing the second surface of the antenna substrate and an inclined region facing a direction different from the inner wall, the inclined region may be formed in a direction forming a predetermined angle with the direction in which the resting region is facing, and the inner wall may include a slit region extending from both ends of the resting region and including slits. In addition, various embodiments identified through the specification are possible.
Patent EP-4044907-A1 (EP)
Inventor: PETERSON MATTHEW J
IPC: A61B5/00
Filed: 2020-10-14
Abstract: Methods and systems for imaging and analysis are described. Accurate pressure ulcer measurement is critical in assessing the effectiveness of treatment. However, the traditional measuring process is subjective. Each health care provider may measure the same wound differently, especially related to the depth of the wound. Even the same health care provider may obtain inconsistent measurements when measuring the same wound at different times. Also, the measuring process requires frequent contact with the wound, which increases risk of contamination or infection and can be uncomfortable for the patient. The present application describes a new automatic pressure ulcer monitoring system (PrUMS), which uses a tablet connected to a 3D scanner, to provide an objective, consistent, non-contact measurement method. The present disclosure combines color segmentation on 2D images and 3D surface gradients to automatically segment the wound region for advanced wound measurements.
Patent EP-4045093-A1 (EP)
Inventor: WU TIANYU
IPC: A61K48/00
Filed: 2020-10-14
Abstract: L'invention concerne des compositions et des méthodes de traitement de pathologies cardiaques et d'autres maladies. Dans certains modes de réalisation, l'invention concerne des compositions et des procédés permettant la distribution de canaux sodiques. Les compositions sont particulièrement appropriées dans des applications de thérapie génique et pour les implantations de patch de tissu cardiaque.
Patent EP-4049201-A1 (EP)
Title: System and method for forecasting real estate solutions
Inventor: O'MOORE MARSHALL
IPC: G06Q10/06
Filed: 2020-10-21
Abstract: A computer-implemented system and method of analyzing historical business data and business objectives for real estate solution prediction is provided. The method includes receiving a user dataset associated with a business entity by a server computing device. The server may determine a set of forecasted headcounts at different points of future time based o a historical headcount, generate a plurality of scenarios associated with the business entity based on the forecasted headcount and the commercial objective dataset, and construct option trees with respective real estate solutions corresponding to respective scenarios. A neural network system may be configured to perform stress tests against respective scenarios to evaluate respective real estate solutions and determine respective costs and actions associated with respective real estate solutions. The computing device may determine an optimal real estate solution with a minimized cost and a corresponding action that the business entity takes to minimize the costs.
Patent EP-4030920-A1 (EP)
Title: Production of fermented milk products from natural isolate starter cultures
Inventor: AH NER MEHMET
IPC: C12R1/46
Filed: 2020-10-19
Abstract: With the invention, it is possible to commercialize  Streptococcus thermophilus  and  Lactobacillus bulgaricus  bacteria, which are naturally found in local village yogurts in Anatolia, after isolation and purification, and with a process designed for the use of starter cultures containing different combinations of these bacteria, creamy yogurt, homogenized yogurt, fermented milk products such as yogurt and ayran with different fat/dry matter contents are produced. With the invention, by using completely natural isolates isolated from yogurt taken from the local villages of Anatolia, which does not have any modifications; a sustainable method has been developed that can be applied industrially within the scope of mass production and is suitable for the standard structure and taste that consumers in our country want to see in yogurt. With the invention, natural fermented milk products are produced with starter cultures known as yeast/living yogurt cultures in colloquial language and TGK Nutrition and Health Declarations Regulation.
Patent EP-4052806-A1 (EP)
Inventor: TOMIZAWA SHIGERU
IPC: C09D5/00
Filed: 2020-07-03
Abstract: Provided is an aqueous coating composition that can exhibit high coating film performance even when cured at a relatively low temperature. The present invention pertains to an aqueous coating composition comprising (A) a hydroxyl group-containing resin and (B) a blocked polyisocyanate compound. The weight average molecular weight of the blocked polyisocyanate compound (B) is in a range of 20,000-200,000.
Patent EP-4051657-A1 (EP)
Inventor: NAGARAJAN HARISH
IPC: C07C31/20
Filed: 2020-10-28
Abstract: The present disclosure provides microbial organisms having decreased production of unwanted by-products (e.g, pyruvate-, CO 2- , TCA-derived by-products; acetate; ethanol; and/or, alanine) to enhance carbon flux through acetyl-CoA, which can increase production of acetyl- CoA derived compounds (e.g, 1,3-BDO, MMA, and (3R)-hydroxybutyl (3R)-hydroxybutyrate, or any other acetyl-CoA derived compounds), and products made from any of these compounds. Also provided are one or more exogenous nucleic acids encoding enzymes that can decrease production of unwanted by-products (e.g, aldehyde dehydrogenase, acetyl-CoA synthase, D-amino acid dehydrogenase, alanine racemase, and/or citrate synthase), and/or one or more gene attenuations occurring in genes (e.g., acetolactate synthase) that result in decreased production of unwanted by-products. Various combinations of the exogenous nucleic acids and gene deletions are also provided in the present disclosure. Methods of making and using the same, including methods for culturing cells, and for the production of the various products are also provided.
Patent EP-4022966-A1 (EP)
Inventor: LEE YOUNGDAE
IPC: H04W72/14
Filed: 2020-11-09
Abstract: La présente invention concerne le rapport d'état de canal dans un système de communication sans fil. Selon un mode de réalisation de la présente invention, un procédé mis en œuvre par un premier dispositif sans fil dans un système de communication sans fil consiste à : établir une connexion de contrôle de ressources radio (RRC) PC5 entre le premier dispositif sans fil et un second dispositif sans fil ; recevoir des informations de contrôle de liaison latérale (SCI) du second dispositif sans fil, les SCI ordonnant au premier dispositif sans fil d'effectuer un rapport d'informations d'état de canal (CSI) de liaison latérale (SL) pour la connexion RRC PC5 ; déclencher le rapport SL-CSI ; et sur la base de l'indisponibilité d'une ressource de liaison latérale pour le rapport SL-CSI et de la configuration du premier dispositif sans fil avec un mode dans lequel des ressources de liaison latérale sont programmées par un réseau, transmettre un signal relatif au rapport CSI-CSI pour demander la ressource de liaison latérale au réseau.
Patent EP-4059313-A1 (EP)
Title: Connectivité activée par réseau pour des liaisons de communication désavantagées
Inventor: KÖSE CENK
IPC: H04W40/12
Filed: 2020-11-10
Abstract: L'invention concerne des dispositifs, des systèmes et des procédés permettant de fournir une connectivité activée par réseau pour des liaisons de communication désavantagées dans des réseaux sans fil. Un procédé donné à titre d'exemple permettant d'activer une connectivité sur une liaison désavantagée consiste à : recevoir par le biais d'un premier nœud d'une pluralité de nœuds, en provenance d'un nœud source dans la première bande de fréquences dans un premier créneau temporel, un premier signal comprenant un message ; recevoir, par le biais du premier nœud, en provenance d'au moins un second nœud dans une seconde bande de fréquences dans un second créneau temporel, un second signal qui est utilisé pour générer une première mesure de fiabilité correspondant au message ; et mettre en œuvre, d'après une pluralité de mesures de fiabilité correspondant au message et à la première mesure de fiabilité, une opération de traitement sur le message, la première bande de fréquences ne chevauchant pas la seconde bande de fréquences, et une durée du premier créneau temporel étant supérieure à une durée du second créneau temporel.
Patent EP-4062847-A1 (EP)
Inventor: TAJIMA TOMOYUKI
IPC: A61B18/14
Filed: 2020-09-29
Abstract: Provided are a medical device and a treatment method capable of locally radiating energy to a treatment target site by bringing an energy radiation unit, which is capable of radiating the energy in a non-contact state with respect to a living organ, close to the treatment target site.At a distal portion of a shaft 110 of a guide portion 100 included in a medical device 10, a first portion 115a configured to be capable of coming into contact with an inner wall of a living organ, and a second portion 115b disposed on a proximal side of the shaft with respect to the first portion and configured to be capable of coming into contact with the inner wall of the living organ at a position different from that of the first portion on a transverse cross section of the inner wall of the living organ are formed, and a treatment portion 200 is movable in a lumen 113 of the shaft in a state where at least a part of the first portion and at least a part of the second portion come into contact with the inner wall of the living organ.
Patent EP-4065124-A1 (EP)
Inventor: REDDY KIRAN
IPC: A61K31/551
Filed: 2020-11-25
Abstract: La présente invention concerne, en partie, des composés hétéroaryle fusionnés et des compositions utiles pour prévenir et/ou traiter une maladie ou une affection se rapportant à une fonction aberrante d'un canal ionique de sodium sensible à la tension, par exemple, un courant de sodium anormalement tardif/persistant. L'invention concerne également des procédés de traitement d'une maladie ou d'une affection liée à une fonction aberrante d'un canal ionique sodique impliquant des troubles neurologiques (par exemple, le syndrome de Dravet, l'épilepsie), une douleur et des troubles neuromusculaires.
Patent EP-4064992-A1 (EP)
Inventor: IONITA CIPRIAN
IPC: G16H50/00
Filed: 2020-11-27
Abstract: Methods and systems are provided for assessing a vasculature of an individual. In an embodiment of a method, one or more angiographic parametric imaging (API) maps of the vasculature are obtained, wherein each API map of the one or more API maps encodes a hemodynamic parameter. A state of the vasculature is determined using a machine-learning classifier applied to the one or more API maps.
Patent EP-4078524-A1 (EP)
Inventor: KAGAN ASAF
IPC: G06T7/73
Filed: 2020-12-14
Abstract: A system uses data captured by vehicle-mounted sensors to generate a view of a ground surface. The system does this by receiving digital image frames and associating a location and pose of the vehicle that captured the image with each digital image frame. The system will access a three dimensional (3D) ground surface estimation model of the ground surface, select a region of interest (ROI) of the ground surface, and select a vehicle pose. The system will identify digital image frames that are associated with the pose and also with a location that corresponds to the ROI. The system will generate a visual representation of the ground surface in the ROI by projecting ground data for the ROI from the ground surface estimation model to normalized 2D images that are created from the digital image frames. The system will save the visual representation to a two-dimensional grid.
Patent EP-4081276-A1 (EP)
Inventor: FARROW WADE P
IPC: A61B17/32
Filed: 2020-12-24
Abstract: A method of treating or cleaning a wound bed is disclosed. The method includes obtaining a wound-care device (10). The wound-care device (10) includes a handle (12) and a head (14) monolithically formed with a first end of the handle (12) and extending away from the first end of the handle (12). The head (14) includes a base (80) and a plurality of projections (82) monolithically formed with the base (80) and extending away from the base (80). During use of the wound-care device (10), a user may manually disturb a wound bed of a patient by placing one or more projections (82) of the plurality of projections (82) in contact with the wound bed and manually moving, while the one or more projections (82) are in contact with the wound bed, the wound-care device (10) with respect to the wound bed.
Patent EP-4083009-A1 (EP)
Inventor: SHIMIZU MASAHIKO
IPC: C07C29/80
Filed: 2020-12-23
Abstract: A high-purity 1,3-butylene glycol product that is colorless and odorless (or almost colorless and odorless), unlikely to cause coloration and odor over time, and/or unlikely to cause an acid concentration increase over time when the product is left in a state containing water is provided. A 1,3-butylene glycol product containing 1,3-butylene glycol, wherein, after the 1,3-butylene glycol product has been kept at 180°C for 3 hours in air atmosphere, at least one of contents of compounds represented by the following Formula (A) or (B) is less than 8 ppm. In the following formula, R<sup>1</sup> to R<sup>4</sup> are the same as or different from each other, and each of R<sup>1</sup> to R<sup>4</sup> is a hydrogen atom, an alkyl group which has from 1 to 4 carbon atoms and may be substituted with a hydroxy group, or an alkenyl group which has from 2 to 4 carbon atoms and may be substituted with a hydroxy group.